Related Experiment Video
Updated: May 23, 2026
07:54
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
['Malignant peritoneal mesothelioma': a condition difficult to diagnose]
Fleurtje M van der Valk1, Jan van Leeuwen
1Universitair Medisch Centrum Groningen, afd. Interne Geneeskunde, Groningen, the Netherlands. f.m.valkvander@amc.uva.nl
Nederlands Tijdschrift Voor Geneeskunde
|April 13, 2012
Summary
Malignant peritoneal mesothelioma, a rare cancer, is increasingly diagnosed due to asbestos exposure. Histological examination is crucial for diagnosis, with multimodal therapy offering survival benefits.
Area of Science:
- Oncology
- Pathology
Background:
- Malignant mesothelioma arises from serous membranes like the pleura and peritoneum.
- Malignant peritoneal mesothelioma is a rare but increasing malignancy, linked to historical asbestos use.
Observation:
- A 60-year-old male presented with constitutional symptoms including malaise, night sweats, and weight loss.
- Diagnostic workup involved CT scans, PET-CT scans, laparoscopies, and peritoneal biopsies.
- Diagnosis of malignant peritoneal mesothelioma was established after a 7-month investigation period.
Findings:
- Histological examination of peritoneal biopsies is critical for diagnosing malignant peritoneal mesothelioma.
- Optimal treatment strategies remain under investigation, lacking universal consensus.
- Systemic chemotherapy and hyperthermic intraperitoneal chemotherapy post-cytoreductive surgery show potential for survival improvement.
Implications:
- Emphasizes the diagnostic importance of histopathology in suspected malignant peritoneal mesothelioma.
- Highlights the need for further research into standardized, effective treatment protocols.
- Suggests that aggressive, multimodal therapeutic approaches may enhance patient survival outcomes.
